Clinical Application of Endoret® (Plasma Rich in Growth Factors) in Refractory Ocular Surface Disease Patients. PRGF is a personalised technology that has revolutionised the field of regenerative medicine. Its application over the last decade has extended to many...
Progress in the use of plasma rich in growth factors in ophthalmology: from ocular surface to ocular fundus. Introduction: The use of blood derivatives and especially Plasma rich in growth factors (PRGF), for regenerative purposes has been a common trend along the...